Investment bank Lazard
Corporate advisors such as Lazard and Evercore saw improved quarterly results as they benefited from a higher number of deals in an improving economy. However, their bigger peers such as Goldman Sachs
A look at the numbers
Operating revenue for the quarter increased to $491.7 million from $438.3 million, up 12% on a year-on-year basis, helped by higher brokerage commissions and its merger business. During the quarter, Lazard helped close Mosaic's
Revenue from the firm's asset management business increased by almost 27% to $237.7 million. Higher asset management fees coupled with increased deal-making this quarter helped send net income higher. Net income rose to $65.8 million from $53.0 million, up 24% from the year-ago period.
It set a new record in assets under management which rose to an all time high of $161.6 billion, up a staggering 31% from last year.
Lazard has been looking to return as much cash back to its shareholders as possible. The company repurchased 3.2 million shares this fiscal year. To add to that, it bumped up its quarterly dividend by nearly 28%, which should come as more good news to shareholders.
What lies ahead?
As financial markets have improved faster than economic conditions, we see a number of companies entering into deals and looking at acquisitions as a means of inorganic growth. The resumption of deals has benefited investment and brokerage firms such as Lazard. Lazard is currently overseeing Express Scripts and Medco's
The Foolish bottom line
Lazard, all in all, had a good quarter this time out. It is currently overseeing a number of deals that should add to both its top- and bottom-line growth. Also as the economic situation improves, more and more deals could lie ahead, thus benefiting Lazard in the process. Investors should take note.
